Role of Myokines in Myositis Pathogenesis and Their Potential to be New Therapeutic Targets in Idiopathic Inflammatory Myopathies
Idiopathic inflammatory myopathies (IIM) represent a heterogeneous group of autoimmune diseases whose treatment is often a challenge. Many patients, even after immunosuppressive therapy, do not respond to treatment, so new alternatives have been sought for this. Therefore, other signaling pathways t...
Saved in:
Main Authors: | Vlad Mageriu, Emilia Manole, Alexandra E. Bastian, Florica Staniceanu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2020/9079083 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Myokines as Possible Therapeutic Targets in Cancer Cachexia
by: Emilia Manole, et al.
Published: (2018-01-01) -
Emerging therapeutics in idiopathic inflammatory myopathy
by: Shinji Sato
Published: (2020-01-01) -
Fever, Myositis, and Paralysis: Is This Inflammatory Myopathy or Neuroinvasive Disease?
by: Aneeta R. Kiran, et al.
Published: (2016-01-01) -
Repository Corticotropin Injection for Treatment of Idiopathic Inflammatory Myopathies
by: Aarat Patel, et al.
Published: (2016-01-01) -
Intravenous immunoglobulin in the management of idiopathic inflammatory myositis: A single centre retrospective review
by: Jeet Hemantkumar Patel, et al.
Published: (2020-01-01)